CLINICAL PROFILE OF MYCOPLASMA PNEUMONIA INFECTION AMONG CHILDREN WITH PNEUMONIA
Not Applicable
- Conditions
- Health Condition 1: J157- Pneumonia due to Mycoplasma pneumoniae
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.All children between 2 months to 12 years of age admitting with symptoms suggestive of community acquired pneumonia as per the WHO criteria (Cough, cold, fast breathing and chest indrawing
Exclusion Criteria
1.Children with aspiration pneumonia with neurodevelopmental delay
2.Children with hospital acquired pneumonia( pneumonia developing 72 hrs after admission or within 7 days of discharge)
3.Children with co morbid conditions prone to cause recurrent pneumonias(congenital heart diseases, airway anomalies, cystic fibrosis,congenital or acquired immunodeficiency
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method This study aims to identify any specific clinical markers that helps in the diagnosis of mycoplasma and reduce the usage of unwarranted and empirical macrolides in community acquired pneumonia cases.Timepoint: February 2020 to february 2021
- Secondary Outcome Measures
Name Time Method This study also aims to identify the sensitivity pattern of the mycoplasma pneumonia to macrolides.Timepoint: February 2020 to february 2021